Citrates

EU Citrate Compliance 2026

What Food, Pharma and Nutraceutical Buyers Must Know 2026 EU Additive Amendments: What Citrate Buyers Should Know Commission Regulations (EU) 2026/189 and 2026/196 entered into force on 18 February 2026. Regulation 2026/196 introduces mandatory microbiological criteria for hydrocolloids and E1450 used in infant foods and FSMP. Citrates (E331 to E333) are not directly amended, but the regulation establishes a clear industry direction that progressive buyers are already applying to all additive su...
Read More

Calcium Citrate vs Calcium Carbonate

The Definitive Bioavailability Guide for Pharmaceutical and Nutraceutical Formulators If you are formulating calcium supplements, fortified foods, or pharmaceutical preparations for the European or global market, you have likely defaulted to calcium carbonate for its cost efficiency and high elemental calcium content. But the science of calcium absorption tells a more nuanced story, and choosing the wrong calcium source can mean your end consumers absorb significantly less calcium than your labe...
Read More

Pharmaceutical-Grade Citrate Sourcing for EU Manufacturers: CBAM, Green GMP & Traceability

What Is Driving the Shift in EU Excipient Sourcing? European pharmaceutical and food manufacturers are facing a new sourcing reality. Stricter EU Green GMP guidelines, the upcoming expansion of the Carbon Border Adjustment Mechanism (CBAM), and a growing demand for supply chain transparency are forcing procurement teams to rethink how and where they buy citrate ingredients. The manufacturers that adapt fastest will gain both a compliance advantage and a cost advantage. Those who wait risk disrup...
Read More
en_USEnglish